InvestSMART

Micro-X Limited (ASX: MX1) - Share Price

Current share price for MX1 : $0.033 0.001 (2.94%)+

Micro-X Limited (MX1), an ASX-listed company, is a Company that is engaged in design, development, manufacturing and commercialisation of imaging products for the global healthcare and security markets utilising Micro-X's proprietary cold cathode X-ray technology.

MX1 General Information +

ASX Code MX1
Website N/A
Industry/Sector Health Care Equipment
Market Cap ($M) 24
MX1 Share Price $0.033
Day High $0.034
Day Low $0.033
Last Close $0.034
MX1 Share Price Movement $0.00 ( 2.94% )
Prices as at 16:40, 10 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Micro-X Limited (MX1) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Micro-X Limited (MX1) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Micro-X Limited (MX1) price-sensitive announcements

MX1 - MX1 - Micro-X Completes Full Body CT Critical Design Review
Micro-X Limited, an Australian high-tech company specializing in cold cathode X-ray techno
Micro-X Limited (MX1)
10 Jun 2026 | 9:43 AM
MX1 - MX1 - Human Imaging Study Commences with Micro-X Head CT
Micro-X Limited announced the commencement of a multi-centre pilot study using their Head
Micro-X Limited (MX1)
3 Jun 2026 | 12:06 PM
MX1 - $1.3m Checkpoint Contract Extension Awarded by DHS
Micro-X Limited, an Australian hi-tech company specializing in cold cathode X-ray technolo
Micro-X Limited (MX1)
19 May 2026 | 9:15 AM
MX1 - MX1 - Quarterly Activities Report & Appendix 4C
The Quarterly Activities Report and Appendix 4C from Micro-X Limited for the quarter ended
Micro-X Limited (MX1)
30 Apr 2026 | 12:45 PM

Micro-X Limited (MX1) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Micro-X Limited (MX1)
ORDINARY FULLY PAID
 Health Care $25 Change in substantial holding 7 Jul 2026 4:39PM $0.036 $0.033 fallen by 8.33%
Micro-X Limited (MX1)
ORDINARY FULLY PAID
 Health Care $25 Change in substantial holding 30 Jun 2026 4:35PM $0.035 $0.033 fallen by 5.71%
Micro-X Limited (MX1)
ORDINARY FULLY PAID
 Health Care $25 MX1 - Notice Under Section 708A(5) of the Corporations Act 30 Jun 2026 12:13PM $0.033 $0.033 fallen by 0%
Micro-X Limited (MX1)
ORDINARY FULLY PAID
 Health Care $25 Application for quotation of securities - MX1 30 Jun 2026 12:09PM $0.033 $0.033 fallen by 0%
Micro-X Limited (MX1)
ORDINARY FULLY PAID
 Health Care $25 Application for quotation of securities - MX1 25 Jun 2026 3:55PM $0.033 $0.033 fallen by 0%
Micro-X Limited (MX1)
ORDINARY FULLY PAID
 Health Care $25 MX1 - Investor Presentation 25 Jun 2026 10:00AM $0.034 $0.033 fallen by 2.94%

MX1 Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$13.90 -$2.30 29.60% 0.00 0.00 0.00% 0.0%
2024A -$9.39 -$1.80 -18.10% 0.00 0.00 0.00% 0.0%
2023A -$10.75 -$2.20 -41.60% 0.00 0.00 0.00% 0.0%

MX1 Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Cochlear Limited (COH) $8,089M 0.0171 -0.1883 0.0862 20.6674 25.4617 23.4420 3.48% 2.80% 2.99%
Fisher & Paykel Healthcare Corporation Limited (FPH) $19,387M 0.1388 0.1332 0.1884 49.9168 44.0486 37.0649 1.31% 1.40% 1.59%
Micro-X Limited (MX1) $25M 0.2955 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
ResMed Inc. (RMD) $18,004M 0.3087 9.7669 0.0811 208.4594 19.3612 17.9084 1.10% 1.16% 1.22%

MX1 Directors

Name Position Start Date
Mr James (Jim) White McDowell Non-Executive Director 1 Jan 2021
Ms Ilona Meyer Non-Executive Director 7 Mar 2022
Mr Andrew Hartmann Non-Executive Director 15 Dec 2022
Mr Patrick Gerard O'Brien Non-Executive Director, Non-Executive Chairman 6 Aug 2015

Micro-X Limited (MX1) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
24 Apr 2026 O'BRIEN, Patrick Issued Indirect Shares 2,500,000 $0.080 $200,000.000
8 May 2025 MEYER, Ilona Issued Direct Shares 357,143 $0.070 $25,000.000
8 May 2025 HARTMANN, Andrew Issued Direct Shares 357,143 $0.070 $25,000.000

See all changes in directors' interest & trades for Micro-X Limited (MX1) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

MX1 Management

Name Position
Brian Gonzales CEO Americas & Chief Scientific Officer
Kingsley Hall Chief Executive Officer
Anthony Skeats Chief Operating Officer
Richard Walter Willson Company Secretary

MX1 Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Micro-X Limited (MX1). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
86,540,365 (12.97%) Perennial Value Management Limited
71,089,457 (10.95%) Acorn Capital Limited
54,130,053 (8.11%) Varex Imaging Corporation
45,152,777 (6.67%) TIGA Trading Pty Ltd

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.